MARKET WIRE NEWS

Hypera S.A. (HYPMY) Q4 2024 Earnings Call Transcript

Source: SeekingAlpha

2025-03-21 12:27:29 ET

Hypera S.A. (HYPMY)

Q4 2023 Earnings Conference Call

March 21, 2025, 10:00 AM ET

Company Participants

Breno Toledo Pires de Oliveira - Chief Executive Officer

Adalmario Ghovatto Satheler do Couto - Investor Relations Officer

Ramon Sanches Frutuoso Silva - Chief Financial Officer

Conference Call Participants

Joseph Giordano - JP Morgan

Robert Ford - Bank of America

Mauricio Cepeda - Morgan Stanley

Vinicius Figueiredo - Itau BBA

Samuel Alves - BTG Pactual

Presentation

Operator

Good morning, ladies and gentlemen. Welcome to Hypera Pharma's Earnings Call for the Fourth Quarter of 2024. We have with us Mr. Breno Oliveira, CEO; Ramon Silva, CFO; and Adalmario Couto, IRO.

This event is being recorded. The video can be seen at the company's Investor Relations website, ri.hypera.com.br. We would also like to inform you that all participants will be in listen-only mode. We will then have a Q&A session. Further instructions will be given at this time....

Read the full article on Seeking Alpha

For further details see:

Hypera S.A. (HYPMY) Q4 2024 Earnings Call Transcript
Hypera Pharma - ADR

NASDAQ: HYPMY

HYPMY Trading

1.41% G/L:

$4.4825 Last:

3,934 Volume:

$4.50 Open:

mwn-alerts Ad 300

HYPMY Latest News

August 06, 2025 05:31:34 am
Expected earnings - Hypera S.A. ADR
April 22, 2025 06:52:51 pm
Top 5 Penny Stocks - Healthcare

HYPMY Stock Data

$2,821,821,761
632,766,400
N/A
N/A
Pharmaceuticals
Healthcare
BR

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App